close
MENU
Hot Topic DEALMAKERS
Hot Topic DEALMAKERS
General Business
8 mins to read

Gaining Momentum: clinical research merger heats up healthcare

Genesis Capital’s merger of P3, AusTrials, and Holdsworth House feeds global PE consolidation trend.

Momentum Clinical Research CEO Joshua Stent.

Will Mace Tue, 25 Jun 2024

In just a week’s time, the formal combination and rebrand of three clinical research businesses – New Zealand’s P3 Research, along with AusTrial and Holdsworth House from Australia – will have been completed, representing just the most recent deal in a spate of consolidation in the

Want to read more? It's easy.

Choose your best value subscription option

Student

Exclusive offer for uni students studying at a New Zealand university (valued at $499).
Individual
Group membership
NBR Marketplace

Yearly Premium Online Subscription

NZ$499.00 / yearly

Monthly Premium Online Subscription

NZ$44.95 / monthly

Smartphone Only Subscription

NZ$24.95 / monthly

Premium Group Membership 10 Users

NZ$350+GST / monthly

$35 per user - Pay by monthly credit card debit

Premium Group Membership 20 Users

NZ$600+GST / monthly

$30 per user - Pay by monthly credit card debit

Premium Group Membership 50 Users

NZ$1250+GST / monthly

$25 per user - Pay by monthly credit card debit

Premium Group Membership 100 Users

NZ$1875+GST / monthly

$18.75 per user - Pay by monthly credit card debit

Yearly Premium Online Subscription + NBR Marketplace

NZ$499.00 / yearly

Already have an account? Login
Will Mace Tue, 25 Jun 2024
Contact the Writer: william@nbr.co.nz
News tip? Question? Typo? Let us know: editor@nbr.co.nz
© All content copyright NBR. Do not reproduce in any form without permission, even if you have a paid subscription.
Gaining Momentum: clinical research merger heats up healthcare
General Business,
104643
true